Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ivan Hung and Alan Wu.
Ivan Hung
Connection Strength
0.615
Alan Wu
  1. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020 05 30; 395(10238):1695-1704.
    View in: PubMed
    Score: 0.220
  2. Unique Clusters of Severe Acute Respiratory Syndrome Coronavirus 2 Causing a Large Coronavirus Disease 2019 Outbreak in Hong Kong. Clin Infect Dis. 2021 07 01; 73(1):137-142.
    View in: PubMed
    Score: 0.060
  3. Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms. Infection. 2021 Apr; 49(2):257-265.
    View in: PubMed
    Score: 0.056
  4. Development and validation of risk prediction models for COVID-19 positivity in a hospital setting. Int J Infect Dis. 2020 Dec; 101:74-82.
    View in: PubMed
    Score: 0.056
  5. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses. Immunity. 2020 10 13; 53(4):864-877.e5.
    View in: PubMed
    Score: 0.056
  6. A Rapid, Simple, Inexpensive, and Mobile Colorimetric Assay COVID-19-LAMP for Mass On-Site Screening of COVID-19. Int J Mol Sci. 2020 Jul 29; 21(15).
    View in: PubMed
    Score: 0.056
  7. Olfactory Dysfunction in Coronavirus Disease 2019 Patients: Observational Cohort Study and Systematic Review. Open Forum Infect Dis. 2020 Jun; 7(6):ofaa199.
    View in: PubMed
    Score: 0.055
  8. Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection. J Clin Virol. 2020 08; 129:104476.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.